Your search relates to more than one category
Chicago Tribune (Free subscription) | 11/26/2009
Facility would be used to make flu, pandemic vaccines Deerfield-based Baxter International Inc. says it is looking into building a cell-based vaccine manufacturing plant in the U.S. to produce seasonal and pandemic flu vaccines.
Chicago Tribune (Free subscription) | 11/26/2009
Deerfield-based Baxter International Inc. says it is looking into building a cell-based vaccine manufacturing plant in the U.S. to produce seasonal and pandemic flu vaccines.
BloggingStocks (Free subscription) | 11/24/2009
Filed under: Baxter Intl (BAX) , Stocks to Buy "Baxter International ( BAX ) benefits from a robust balance sheet, solid operating momentum, and rising earnings estimates," says blue chip advisor Richard Moroney in Dow Theory Forecasts . The advisor explains, "The first company to commercially prepare intravenous treatments, Baxter has manufactured and distributed medical...
Connecting the Dots in the New World Order (Free subscription) | 11/24/2009
According to Europe Business Blog: "Joseph Moshe, the dual national (Israeli-American) Mossad biowar expert, who was attacked and seized by Federal Agents and LAPD in mid-August in California, after speaking to Dr. True Ott on his national radio show and warning of a plot by Baxter International to spread a Plague from Baxter's Ukrainian lab, is being held in the Patton State Mental Hospital...
Tuscaloosanews.com (Free subscription) | 11/26/2009
Though still early, the work of Dr. Douglas Losordo that uses technology developed by Baxter International Inc. is being watched closely by the stem cell research community. The trial data, presented Tuesday afternoon at the American Heart Association scientific conference in Orlando, is also important in the study of heart disease, the leading cause of death in the U.S.
thepharmaletter.com (Free subscription) | 11/23/2009
Following its November 16-19 meetings, the European Medicines Agency (EMEA) says it has reviewed further data on the centrally authorized pandemic vaccines, Celvapan (from Baxter International), Focetria (from Novartis) and Pandemrix (from GlaxoSmithKline). The Agency has reaffirmed that they have a positive balance of benefits and risks in the context of the current H1N1 influenza pandemic....
iStockAnalyst.com (Free subscription) | 11/23/2009
"Baxter International (NYSE: BAX) benefits from a robust balance sheet, solid operating momentum, and rising earnings estimates," says Richard Moroney. In Dow Theory Forecasts, he explains, "The ?rst company to commercially prepare intravenous treatments, Baxter has manufactured and distributed medical products since 1931." Here's his bullish [More...]
WSJ.com (Free subscription) | 11/25/2009
It isn't clear how many benefits cell-culture technology will offer. A spokeswoman for Illinois-based Baxter International Inc. said the company's cell-culture plant in the Czech Republic—one of the first large-scale cell-culture facilities—initially experienced the same difficulty growing the H1N1 virus that egg-based plants did. Like other drug makers, Baxter managed to improve the yield,...
What Really happened (Free subscription) | 11/22/2009
Joseph Moshe Update: November 18, 2009 According to Europe Business Blog: "Joseph Moshe, the dual national (Israeli-American) Mossad biowar expert, who was attacked and seized by Federal Agents and LAPD in mid-August in California, after speaking to Dr. True Ott on his national radio show and warning of a plot by Baxter International to spread a Plague from Baxter's Ukrainian lab, IS BEING...
TruthSeeker24's anti-N.W.O. corner (Free subscription) | 11/22/2009
... dual national (Israeli-American) citizenship, Moshe was later seized for blowing the whistle on Baxter International contacting a radio show and the White House, warning them of the pharmaceutical companies’ plot to spread a plague from Baxter’s Ukrainian lab. He knew the FBI was bugging his house, so he decided to pack up his things and head for the Israeli consulate where he...
